Oral GLP-1 RAs are also under development, and early data show similar weight loss efficacy to semaglutide 2.4 mg [84], which could improve convenience and potentially reduce costs through improved manufacturing and distribution efficiency
Are GLP-1 drugs covered by insurance in India
As phase III trial data for retatrutide emerge and regulatory submissions are made, it is anticipated that formal guidance will be developed
Nausea, diarrhea, and vomiting were the most common complaints, occurring primarily during dose escalation periods
However, naturally produced GLP-1 has a very short half-lifeapproximately 2 to 3 minutesbecause it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4)
It represents a new class of triple-agonist metabolic therapy with the potential to redefine fat loss, body recomposition, and metabolic health